Investors
Novartis Venture Fund
https://nvfund.comNovartis Venture Fund, based in Basel, focuses on companies developing new treatments and technologies in the health and science sectors. They typically invest in Series A and Series B stages, concentrating on biotech, pharma, and hardware fields. Notable investments include CatalYm and Rappta Therapeutics. Their goal is to support businesses creating novel therapeutics and platforms.
Recent Investments
- CatalYmSeries D(
56 ) - DeciphexSeries B( 31 )
- AstronauTxSeries A( 48 )
- CatalYmUnknown( 56 )
- EpsilogenUnknown( 52 )
- DopavisionSeries A( 37 )
- AnaveonUnknown( 48 )
- Splice BioSeries A( 26 )
- CatalYmSeries B( 56 )
- Rappta TherapeuticsSeries A( 37 )
- AnaveonSeries A( 48 )
- Enterprise TherapeuticsSeries B( 52 )